Skip to main content
Download PDF

De novo disruptive heterozygous MMP21 variants are potential predisposing genetic risk factors in Chinese Han heterotaxy children

Human Genomics volume 16, Article number: 41 (2022) Cite this article

Abstract

Background

Heterotaxy syndrome (HTX) is caused by aberrant left–right patterning early in embryonic development, which results in abnormal positioning and morphology of the thoracic and abdominal organs. Currently, genetic testing discerns the underlying genetic cause in less than 20% of sporadic HTX cases, indicating that genetic pathogenesis remains poorly understood. In this study, we aim to garner a deeper understanding of the genetic factors of this disease by documenting the effect of different matrix metalloproteinase 21 (MMP21) variants on disease occurrence and pathogenesis.

Methods

Eighty-one HTX patients with complex congenital heart defects and 89 healthy children were enrolled, and we investigated the pathogenetic variants related to patients with HTX by exome sequencing. Zebrafish splice-blocking Morpholino oligo-mediated transient suppression assays were performed to confirm the potential pathogenicity of missense variants found in these patients with HTX.

Results

Three MMP21 heterozygous non-synonymous variants (c.731G > A (p.G244E), c.829C > T (p.L277F), and c.1459A > G (p.K487E)) were identified in three unrelated Chinese Han patients with HTX and complex congenital heart defects. Sanger sequencing confirmed that all variants were de novo. Cell transfection assay showed that none of the variants affect mRNA and protein expression levels of MMP21. Knockdown expression of mmp21 by splice-blocking Morpholino oligo in zebrafish embryos revealed a heart looping disorder, and mutant human MMP21 mRNA (c.731G > A, c.1459A > G, heterozygous mRNA (wild-type&c.731G > A), as well as heterozygous mRNA (wild-type& c.1459A > G) could not effectively rescue the heart looping defects. A patient with the MMP21 p.G244E variant was identified with other potential HTX-causing missense mutations, whereas the patient with the MMP21 p.K487E variant had no genetic mutations in other causative genes related to HTX.

Conclusion

Our study highlights the role of the disruptive heterozygous MMP21 variant (p.K487E) in the etiology of HTX with complex cardiac malformations and expands the current mutation spectrum of MMP21 in HTX.

Background

Early embryonic aberrant left–right asymmetric development leads to a broad spectrum of congenital malformations, including situs inversus and situs ambiguous (also called heterotaxy, HTX) [1, 2]. HTX is a serious congenital malformation characterized by abnormal positioning and morphology of the heart, lungs, and abdominal organs along the left–right axis, occurring in approximately 1/10000–1/5000 live births [3, 4]. More than 90% of HTX patients have complex congenital heart diseases (CHDs), including single ventricle (SV), single atrium (SA), transposition of the great arteries (TGA), double-outlet right ventricle (DORV), complete atrioventricular canal (CAVC), and total anomalous pulmonary venous connection (TAPVC), which account for approximately 3% of all CHDs [4, 5]. Patients with HTX and CHDs face significant complications, such as respiratory dysfunction, valve regurgitation, cardiac insufficiency, and challenging medical and surgical treatments [6,7,8]. Owing to its high clinical mortality and low postoperative survival rate, HTX has become the focus of many studies.

The pathogenesis of HTX is multifactorial and involves both genetic and environmental factors. The environmental factors include in utero retinoic acid exposure, type I maternal diabetes mellitus, and maternal cocaine use [9,10,11]. Although associations between these environmental factors and HTX have been documented, their exact roles remain poorly understood. On the other hand, high-throughput sequencing has identified many genetic factors that play vital roles in the pathogenesis of HTX, such as cilia proteins (DYX1C1, DNAH5, DNAH9, DNAH11, ZMYND10, C11ORF70, LRRC56, PKD2, NUP188, NEK2, FDZ3), NODAL and its relatives (NODAL, CITED2, ACVR2B, ZIC3, CFC1, GDF1, DAND5, LEFTYB, LEFTYA), and left–right organizer proteins (FGFR4, ZIC3, RAPGEF5, GALNT11) [12,13,14,15,16,17,18,19,20,21,22]. Hoverer, genetic testing scans out the underlying genetic cause in less than 20% of sporadic HTX cases, indicating that the genetic pathogenesis of HTX remains poorly understood.

MMP21 is a member of the matrix metalloproteinase (MMP) family and plays an important role in various physiological and pathological processes [23, 24]. The human MMP21 gene is located on chromosome 10q26.2, contains 7 exons, and measures approximately 20 kb [25, 26]. MMP21 regulates embryonic development, particularly neural development [26, 27]. Notably, emerging data have also confirmed its involvement in the pathogenesis of HTX. For example, ENU-induced mice Mmp21 mutants showed laterality defects and complex CHDs [28, 29], while Morpholino oligo (MO)-mediated transient suppression or CRISPR/Cas9-mediated deletion of mmp21 in zebrafish embryos caused cardiac looping defects [29, 30]. Therefore, exome sequencing will be useful for screening novel pathogenetic candidates, expanding the mutational spectrum of patients with syndromic, non-syndromic, and sporadic HTX, ultimately providing a better understanding of the contribution of susceptible alleles to disease penetrance and pathogenesis. HTX-related pathogenic homozygous and compound heterozygous variants of MMP21 were detected in patients with HTX via exome sequencing [18, 19, 29,30,31,32]; however, no studies reported whether simple heterozygous MMP21 variants can cause HTX. Thus, scanning the MMP21 variants in patients with HTX could help clarify the genotype–phenotype correlation and provide clues for genetic counseling.

In this study, we aim to garner a deeper understanding of the genetic factors of HTX by documenting the effect of MMP21 variants on disease occurrence and pathogenesis. We used exome sequencing to detect potential pathogenic variants in a cohort of 81 patients with combined HTX and CHDs and 89 healthy controls. Three rare heterozygous non-synonymous MMP21 variants (p.G244E, p.L277F, p.K487E) were documented in three unrelated patients with HTX and confirmed to be de novo mutations by Sanger sequencing. Two of these variants (p.G244E and p.K487E) were also proven to be deleterious in zebrafish MO rescue experiments. Our data expand the spectrum of MMP21 variants associated with HTX and suggest that heterozygous MMP21 variants may play a role in the pathogenesis of HTX and confer susceptibility to HTX with CHDs.

Methods

Ethical statement

These studies involving human participants were approved by the Medical Ethics Committee of Xinhua Hospital (NO. XHEC-C-2012–018) and Shanghai Children’s Medical Center (NO. SCMC-201015). Human peripheral blood samples were extracted voluntarily when donors signed the informed consent (or their parents/guardian if the donors were too young to consent). Zebrafish experiments were conducted under the approval of the Animal Ethics Committee of Xinhua Hospital, affiliated to Shanghai Jiao Tong University School of Medicine.

Study population

From January 2012 to December 2016, we recruited 81 HTX patients with CHDs and 89 healthy children from Shanghai Children’s Medical Center and Xinhua Hospital. All patients were diagnosed using an echocardiogram, computed tomography, or magnetic resonance imaging. The patient cohort included 50 males and 31 females, with a mean age of 3.01 ± 2.60 years (range 12 days–15 years). All patients had cardiac defects including dextrocardia, mesocardia, left atrium isomerism, right atrium isomerism (RAI), conotruncal defects, and abnormal superior/inferior vena cava. Extracardiac malformations included bronchial inversus, polysplenia/asplenia, and dextrogastria (Table 1). The control cohort included 58 males and 31 females, with an average age of 4.75 ± 3.75 years (range 3 months–13 years). The controls were children presenting for routine health checkups. We informed the children and their parents about the background, purpose, and significance of our study. After obtaining the signed written informed consent of the children and their legal guardians, we included the children in the control group and extracted peripheral blood for exome sequencing. All study participants were Han Chinese and not related to one another. The study design conformed to the guidelines of the Declaration of Helsinki.

Table 1 Cardiac and extracardiac abnormalities of 81 HTX patients with CHDs in this study
Full size table

Exome sequencing identification and Sanger sequencing validation

After obtaining informed consent, we strictly collected whole peripheral blood samples from all participants and stored them in EDTA tubes individually without sample mixup. The QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) was used to isolate genomic DNA. Exome sequencing was performed in 81 HTX patients and 89 control children. Specifically, exome sequencing was performed using a commercial provider (Shanghai Biotechnology Co., Ltd.). Briefly, the SureSelect Human All Exon V6 kit (Agilent Technologies, Santa Clara, CA, USA) and Illumina HiSeq 2500 platform (Shanghai Biotechnology Co., Ltd., Shanghai, China) were used, and raw sequencing reads were compared to the reference human genome (hg19). The mapping ratio of the 170 samples included in this study (case and control) was above 99%, and the average sequencing depth was > 25X. Among all bases in the captured target area, the percentage of coverage ≥ 10 was 98%–99.99%. Exome sequencing data were filtered based on the following criteria: (1) the mutation genotype included exonic non-synonymous, coding indels, splice-site variants, or frameshift; (2) the average depth of sequencing was > 10X; (3) minor allele frequency was < 1% or not found in population-based databases including SNP database at NCBI (http://www.ncbi.nlm.nih.gov/), 1000 Genomes (http://www.1000genomes.org/), ESP6500 (http://evs.gs.washington.edu/EVS/), ExAC (http://exac.broadinstitute.org/), and gnomAD (http://gnomad.broadinstitute.org/).

Sanger sequencing was performed for validating the candidate variants of MMP21 and confirming that all variants were de novo. The PCR primers were designed to amplify the coding regions, including the candidate variants, using Primer premier5 software (Additional file 1: Table S1). We added 250 ng of each genomic DNA sample and 1 μM of each primer to 20 μl of 1 × MyTaq™Mix (Bioline USA Inc.). The PCR conditions were as follows: 98 °C for 2 min; 30 cycles at 98 °C for 20 s, Tm for 30 s, 72 °C for 45 s, and 72 °C for 10 min. We used 1% agarose gel staining with GelRed (Biotium, USA) to analyze 2 μl of PCR products. The residual PCR products were sequenced using an ABI 3730XL sequencer (Applied Biosystems, USA), and the results were compared to reference MMP21 cDNA sequences from NCBI (#NM_147191.1) using the GenBank BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

In silico analysis

Different in silico pathogenicity prediction tools include MutationTaster (http://www.mutationtaster.org/), PROVEAN (http://provean.jcvi.org/), and Polyphen2 (http://genetics.bwh.harvard.edu/pph2/) were used to evaluate possible pathogenic effects of the identified variants (Table 2). Three-dimensional structural models of wild-type (WT) and mutant MMP21 proteins were constructed using SWISS-MODEL (https://www.swissmodel.expasy.org), and the effects of mutant protein configuration changes were analyzed using HOPE (http://www.cmbi.ru.nl/hope/).

Table 2 Clinical information and MMP21 variant characteristics in HTX patients with complex cardiac malformations
Full size table

Alignment of multiple MMP21 protein sequences

The MMP21 amino acid sequences of various species, including Homo sapiens (human), Xenopus tropicalis (frog), Canis lupus familiaris (dog), Danio rerio (zebrafish), Mus musculus (house mouse), Macaca mulatta (rhesus monkey), Rattus norvegicus (rat), and Pan troglodytes (chimpanzee) were downloaded from the UniProt database (http://www.uniprot.org). The Clustal X software (http://www.clustal.org) was used for sequence alignment.

Plasmids and mutagenesis

The pCMV3-Human MMP21 expression vector and pGEM-T-Human MMP21 clone vector containing human MMP21 cDNA (NCBI RefSeq NM_147191.1) were purchased from Sino Biological (Sino Biological, China). The variants p.G244E (NM_147191.1: c.G731A), p.L277F (NM_147191.1: c.C829T), and p.K487E (NM_147191.1: c.A1459G) were introduced into the WT pCMV3-Human MMP21 vector and pGEM-T-Human MMP21 vector using site-mutagenesis primers (Additional file 1: Table S1) via PCR. The accuracy and integrity of all plasmids were verified by Sanger sequencing.

Cell culture and transfection

Human embryonic kidney 293 T (HEK-293 T) cells obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) were cultured in Dulbecco’s modified Eagle’s medium (HyClone, USA) supplemented with 1% penicillin–streptomycin (Gibco, USA) and 10% fetal bovine serum (MP Biomedicals, USA) under a humidified atmosphere (95% air and 5% carbon dioxide) at 37 °C. When cell density in the 6/12-well plate reached 80%, plasmids were transfected into HEK-293 T cells using FuGene HD (Promega, USA) according to the manufacturer’s protocol. Homozygous and heterozygous variants of MMP21 were simulated using the following two transfection schemes: (1) 1 µg of blank, WT, or mutant MMP21 vectors were separately transfected into HEK-293 T cells; (2) 1 µg of blank, WT, or WT and mutant MMP21 vectors (1:1) were transfected into HEK-293 T cells.

Quantitative real-time polymerase chain reaction

Total RNA was extracted from HEK-293 T cells using TRIzol reagent (Invitrogen, USA) after transfection for 36 h. Zebrafish embryos were crushed using a magnetic bead homogenate pulverizer and total RNA was extracted using TRIzol reagent after microinjection of control MO and splice-blocking Morpholino oligo (SB-MO) for 30 h. Subsequently, PrimeScript RT Master Mix (TaKaRa, Japan) was used for reverse transcription. Quantitative real-time amplification was performed using SYBR Premix Ex Taq (TaKaRa, Japan) on an Applied Biosystems 7500 system. Primers were synthesized by Shanghai Sangon Biotechnology Co., Ltd. (Additional file 1: Table S1). The 2−ΔΔCt method was used to calculate the relative expression of MMP21, and human 18sRNA and zebrafish actin were used as internal references [33].

Western blot

After transfection for 48 h, proteins from HEK-293 T cells were extracted using RIPA lysis buffer (Beyotime, China) supplemented with PMSF (1:100). Proteins were then separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and transferred electrophoretically onto polyvinylidene fluoride membranes (Millipore, USA). The membranes were subsequently incubated with 5% skim milk for 1.5 h at room temperature and then with anti-MMP21 (1:650, 55,289-1-AP, Proteintech) and anti–actin antibodies (1:2000, AF5001, Beyotime) overnight at 4 °C. Next, the membranes were incubated with horseradish peroxidase-labeled goat anti-rabbit secondary antibody (1:5000) and goat anti-mouse secondary antibody (1:5000) for 1.5 h at room temperature and detected with Immobilon Western Chemiluminescent HRP Substrate (Millipore, USA) using a chemiluminescence system (BioRad).

Transcriptional synthesis of mRNA in vitro

The WT and mutant pGEM-T-human MMP21 vectors were used as templates. NotI restriction enzymes were selected based on the location of the T7 promoter in the plasmid map to perform single enzyme digestion of the vector and linearize the plasmid. We generated WT and mutant human MMP21 mRNAs by in vitro transcription, mRNA capping, poly-A tail addition, and mRNA purification, using the mMESSAGE mMACHINE™ T7 Transcription Kit (Thermo Fisher Scientific, USA) according to the manufacturer’s protocol. Human MMP21 mRNA was verified using 1% agarose gel electrophoresis.

Zebrafish maintenance

WT AB strains of zebrafish were obtained from China Zebrafish Resource Center and bred under standard laboratory conditions as previously reported [34]. The water in the feeding system was purified circularly using water filtration equipment and maintained at 28 ± 1 °C with a 14 h/10 h light/dark cycle.

Morpholinos and microinjection in zebrafish

SB-MO was designed and synthesized by Gene Tools (OR, USA) to suppress mmp21 (NM_001317753.1) splicing and translation by targeting the exon 3–intron 3 junction (sequences: 5ʹ-AAATGTGCGATTTAAAACCTGTGCA-3ʹ). MO (5ʹ-CCTCTTACCTCAGTTACAATTTATA-3ʹ) was used as a negative control. Sexually mature male and female zebrafish were separately placed in the same mating box at a 1:1 ratio in the evening and mated the following morning. Zebrafish eggs were collected and arranged in the microinjection mold groove and a working solution was injected into the yolk sac of embryos using a pressure microinjection apparatus (Warner PLI-100A, USA) when the embryos were at the 1–2 cell stage. SB-MO efficiency was verified by RT-qPCR of mmp21 cDNA (NM_001317753.1) obtained from whole embryos 30 h after microinjection. A preliminary experiment was then conducted to determine the optimal interventional concentration of SB-MO. Human MMP21 mRNA (300 ng/μL) was used to rescue the phenotype of SB-MO. Since variants found in the patients were heterozygous, we mixed WT and mutant MMP21 mRNAs (1:1) for microinjection to achieve a heterozygous state. Each microinjection had a volume of approximately 2–5 nL, and 470–570 embryos were injected in each group. Embryos were then regularly observed, and their phenotypes within each group were recorded at 48 h post-fertilization (hpf). The phenotypes recorded include death, cardiac location, looping abnormality, pericardial edema, tail deformity, and spinal curvature. Zebrafish embryos were imaged using an SMZ25 microscope (Nikon, Tokyo, Japan) equipped with a digital camera.

Whole-mount in situ hybridization (WISH)

Primers (Additional file 1: Table S1) were designed to amplify zebrafish cmlc2 (NM_131329.3) by PCR via 2 × TransTaq® High Fidelity (HiFi) PCR SuperMix II (TransGen Inc., China). The pGEM®-T Easy Vector System (Promega, USA) was used to construct the cmlc2 antisense probe plasmid. NcoI restriction enzyme was selected to perform single-enzyme digestion of the vector and linearize the plasmid. Digoxigenin (DIG)-labeled cmlc2 antisense RNA probes were transcriptionally synthesized in vitro using an SP6 RNA Polymerase (Promega, USA). The 48 hpf embryos preserved by methanol dehydration were gradually rehydrated, fixed with 4% PFA, and digested with proteinase K (10 μg/mL). After pre-incubation with hybridization buffer at 65 °C for 4 h, the embryos were incubated with Dig-labeled cmlc2 RNA antisense probes at 65 °C overnight. Next, after gradient washing, the 48 hpf embryos were immersed in anti-DIG antibody (Roche, Germany) and shaken slowly at room temperature for 1 h and then at 4 °C overnight. Finally, immunopositive alkaline phosphatase signals of the 48 hpf embryos were visualized using BM Purple (Sigma, Japan) after washing. An SMZ25 microscope (Nikon, Japan) equipped with a digital camera was used to capture images.

Statistical analysis

All measurement data are presented as the mean ± standard error (SEM). The experiments were independently repeated at least three times. Statistical analyses were performed using GraphPad Prism 8. The results of RT-qPCR and western blotting were analyzed using one-way ANOVA with Tukey’s multiple comparison test. The percentage of zebrafish embryonic phenotypes was compared between groups using the chi-square test in zebrafish MO rescue experiments (and Fisher’s exact test). Statistical significance was set at p < 0.05.

Results

Three de novo heterozygous MMP21 variants were identified in three unrelated HTX patients with CHDs

Using exome sequencing, we reached a molecular diagnosis for 25 of the 81 probands (30.9%). Briefly, we identified a total of 28 missense variants pathogenic (or likely pathogenic) in 11 genes known to be associated with HTX (DNAH5, DNAI1, GALNT11, MEGF8, MMP21, NODAL, NPHP4, PKD1L1, ROCK2, SHROOM3, SMAD2) (Additional file 3: Table S3). Additionally, three rare heterozygous non-synonymous MMP21 variants were identified in three unrelated Chinese Han patients with HTX and complex cardiac malformations: p.G244E in dextrocardia, p.L277F in dextrocardia and RAI, and p.K487E in RAI (Table 2; Additional file 2: Table S2). The proportion of patients with MMP21 variants in the clinical cohort was 3.7% (3/81). All MMP21 variants were absent in the 89 controls and the related parents in our study.

Among the three rare heterozygous missense MMP21 variants, p.K487E (NM_147191.1:c.1459A > G, rs779248373) was found in the NCBI SNP, ExAC, and gnomAD databases, and its MAF was 0.0009563 in East Asians, p.L277F (NM_147191.1:c.829C > T, rs1850462241) was only found in the NCBI SNP database and its MAF was 0.000011 in TOPMed and notably, variant p.G244E (NM_147191.1:c.731G > A) has never been previously reported. Sanger sequencing chromatograms of the identified MMP21 variants in the probands and their parents are shown in Fig. 1A.

Fig. 1
figure 1

Validation and in silico analysis of MMP21 variants found in HTX patients with complex CHDs. A Sanger sequencing chromatograms of three heterozygous missense MMP21 variants in patients with HTX and complex CHDs and the corresponding normal sequences in related parents. Arrows represent heterozygous nucleotide changes. B, C Schematic diagrams of MMP21 gene and protein showing the location of the identified MMP21 variants. The base substitutions are in exon3 and exon7, respectively (B). The amino acids consist of the domains of the ZnMC_MMP and HX superfamily (C). D Clustal X alignment of amino acid mutations in MMP21 among different species indicates that all mutations are highly conserved in vertebrates. E Schematic diagram of the three-dimensional structure and corresponding amino acid residues at the mutation sites of WT (left panel) and mutant (right panel) MMP21 proteins that were reconstructed by SWISS-MODEL. Amino acid substitutions in the variants p.G244E and p.K487E resulted in changes in acidity or basicity, which may affect the function of the mutant domain. The amino acid residue in the original position of the variant p.L277F was replaced by a residue that occupies a larger space volume, which may affect the stability of the protein spatial structure

Full size image

Several potential HTX causative variants were also screened in patients harboring MMP21 mutations (Additional file 2: Table S2). In the MMP21-G244E patient, we identified two additional potential HTX-causing missense mutations in Rho-associated coiled-coil containing protein kinase 2 (ROCK2, NM_004850, c.345G > C, p.Q115H, rs564194657) and nucleoporin 188 (NUP188, NM_015354, c.5018C > T, p.P1673L, rs568477773).

The mutants might affect the function of MMP21 by in silico analysis

The three MMP21 variants are distributed in exon3 and exon7 (Fig. 1B), and the corresponding amino acid substitutions are in two conserved domains of the zinc-dependent MMP catalytic domain (ZnMC_MMP) and heme-like repeat sequence (HX superfamily) (Fig. 1C). High pathogenicity scores of the three rare mutation loci, calculated using multiple online bioinformatics software (Mutation taster, PROVEAN, Polyphen2), highlighted the deleterious effect of all mutations (Table 2; Additional file 2: Table S2). The amino acid substitution site was highly conserved in multiple vertebrates, as shown in the amino acid sequence alignment of MMP21 protein using Clustal X software (Fig. 1D), indicating that amino acid substitutions might result in functional alterations of MMP21 protein.

To further investigate the functional effect of the variants, we used SWISS-MODEL to construct the three-dimensional structure of the WT and mutant MMP21 proteins (Fig. 1E). Amino acid substitutions of the p.G244E and p.K487E variants changed the acidity and basicity of the amino acids, which may affect spatial configuration and alter protein function. Phenylalanine (F), which contains a benzene ring, replaced the branched leucine (L) in the p.L227F variant potentially affecting the stability of the catalytic domain. Further analysis of the three-dimensional configuration of the mutant protein by HOPE revealed that the original amino acid residues were replaced by residues with larger spatial volumes (Fig. 1E), which may affect the stability of the protein spatial structure. The physicochemical properties of the mutant amino acid may not be suitable for its spatial position, which affects its interaction with other parts of the protein’s three-dimensional structure (Fig. 1E).

The expression of MMP21 was not affected by the mutations

To explore the effect of the identified variants on MMP21 expression, we constructed mutant MMP21 expression vectors (pCMV3-MMP21-mut1 (p.G244E), pCMV3-MMP21-mut2 (p.L277F), and pCMV3-MMP21-mut3 (p.K487E)). Blank (pCMV3), MMP21 WT, and mutant vectors were separately transfected or co-transfected into HEK293 cells. RT-qPCR results indicated that neither heterozygous nor homozygous mutations affect the transcription level of MMP21 (Fig. 2A, B). Quantitative results of the western blot analysis showed no statistically significant change in dosage between WT and variant MMP21 proteins in both homozygous and heterozygous states (Fig. 2C, D); however, MMP21 protein expression level in the separately transfected Mut3 group showed a downward trend (p = 0.0529).

Fig. 2
figure 2

The variants do not disrupt the expression of MMP21. The blank (pCMV3), MMP21 WT, or mutant vectors (Mut1, c.G731A; Mut2, c.C829T; Mut3, c.A1459G) were separately transfected or co-transfected (WT/mutant = 1:1) into HEK-293 T cells. A, B Relative mRNA expression of MMP21 in HEK-293 T cells transfected with plasmids for 36 h was assessed by RT-qPCR. 18sRNA was used as an internal control. The RNA levels in the WT group were set at 1. There was no significant difference in MMP21 mRNA expression between the WT and mutant groups (all data are shown as the mean ± SEM, and one-way ANOVA with Tukey’s multiple comparisons test was performed for statistical calculation of MMP21 mRNA expression between the WT and mutant groups, n = 3 independent experiments). C, D Relative MMP21 protein expression in HEK-293 T cells transfected with plasmids for 48 h was evaluated using western blot analysis. β-Actin was used as an internal control (left panel). The intensity quantitation of MMP21 WT and mutant protein expression levels were normalized to β-actin expression using ImageJ software (right panel). Quantitative results revealed no significant difference in MMP21 protein expression between WT and mutant groups (all data are shown as the mean ± SEM; one-way ANOVA with Tukey’s multiple comparisons test was used for statistical calculation of MMP21 protein expression between WT and mutant groups, n = 3 independent experiments)

Full size image

Mutant MMP21 mRNA c.731G > A (mut1) and c.1459A > G (mut3) failed to rescue the zebrafish heart looping disorder induced by mmp21 knockdown via SB-MO.

Engineered mutants or transient suppression using Morpholinos for target genes in zebrafish have broadened our understanding of the pathogenic mechanisms of HTX. To investigate whether the identified mutations affected MMP21 protein function and their role in left–right axial development, an mmp21 knockdown zebrafish model was constructed by SB-MO microinjection. We carried out a preliminary experiment to investigate the proper concentration of the standard control MO and SB-MO for microinjection. RT-qPCR suggested that it was 1.0 mM, and showed that SB-MO could effectively block the splicing of mmp21 in zebrafish (Fig. 3A). Also, most zebrafish embryos died in both the experimental and control groups when the working solution concentration reached 1.5 mM, suggesting that MO side effects positively correlated with an increase in dosage.

Fig. 3
figure 3

mmp21 knockdown induced by SB-MO caused heart looping disorder in zebrafish embryos. A Relative mmp21 mRNA expression in zebrafish embryos injected with SB-MO and standard control MO at concentrations of 0.8 mM and 1.0 mM for 30 h was assessed by RT-qPCR. RT-qPCR results showed that microinjection of SB-MO (1.0 mM) significantly decreased the mmp21 mRNA expression in zebrafish embryos compared to the control MO group (data are shown as the mean ± SEM, one-way ANOVA with Tukey’s multiple comparisons test was used for statistical calculation, n = 3 independent experiments, ns: nonsignificant, ****p < 0.0001). B Whole-mount in situ hybridization using a cmlc2 antisense probe to detect cyclization of 48 hfp embryonic cardiac tubes after MO injection. a, b The WT and control MO groups showed normal heart looping (D-loop). c, d, e Zebrafish embryos in the SB-MO group formed an abnormal L-loop on the left side or manifested as ambiguous looping or no loop. f Some zebrafish embryos in the SB-MO group showed tail deformity, which may be caused by side effects of SB-MO. Scale bar, 200 μm

Full size image

Zebrafish cmlc2 encodes cardiac myosin light chain 2, which is an indispensable component for the assembly of thick myofilaments and acts as a heart-specific protein marker [35]. The antisense RNA of cmlc2 was used as a probe to accurately display the outline and cyclization direction of the zebrafish heart tube. Consistent with previous studies [29, 30], in situ hybridization analysis at 48 hfp indicated that the heart looping direction in WT and MO groups was on the right side (D-loop), whereas the SB-MO group showed abnormal heart looping (such as L-loop or no looping) and contour deformity (Fig. 3B). In addition, some embryos exhibited tail deformities and spinal curvatures in the SB-MO group (Fig. 3B).

Next, we investigated whether MMP21 variants could rescue abnormal zebrafish heart looping induced by mmp21 knockdown via SB-MO. To do so, WT and mutant pGEM-T-human MMP21 vectors were used as templates to synthesize mRNA using in vitro transcription. WT and mutant MMP21 mRNA at a concentration of 300 ng/µL was separately microinjected into 1–2 cell stage zebrafish embryos accompanied by SB-MO to compensate for mmp21 knockdown. In the early stage of zebrafish cardiac development, the vital point of the heart tube begins to bend toward the right side at 36 hpf [36]. The heart looping of zebrafish embryos was unambiguously observed under a light microscope at 48 hpf (Fig. 4A). The incidence of heart looping defects was 2.51% in the control MO group and 63.52% in the SB-MO group. Compared with the SB-MO group without human MMP21 mRNA complement, MMP21 WT mRNA effectively reduced the incidence of malformed phenotypes (13.63% vs. 63.52%, p < 0.0001). However, a statistically significant difference compared to the control MO group (13.63% vs. 2.51%, p < 0.0001) remained. Interestingly, Mut1 (c.731G > A: p.G244E) and Mut3 (c.1459A > G: p.K487E) could not as effectively compensate for the effect of mmp21 blockade as the MMP21 WT mRNA (54.96% vs. 13.63%, p < 0.0001; 52.25% vs. 13.63%, p < 0.0001, respectively) (Fig. 4A). On the other hand, Mut2 (c.829C > T: p.L277F) rescued the phenotypes caused by mmp21 SB-MO, similar to MMP21 WT mRNA (15.74% vs. 13.63%, p = 0.3572) (Fig. 4A).

Fig. 4
figure 4

Microinjection of MMP21 mRNA c.731G > A and c.1459A > G failed to rescue the zebrafish heart looping disorder. The WT and mutant human MMP21 mRNAs synthesized using in vitro transcription were separately microinjected or co-microinjected (WT/mutant = 1:1) into 1–2 cell stage zebrafish embryos accompanied by SB-MO to compensate for the mmp21 knockdown. The zebrafish heart looping disorder phenotype at 48 hfp was observed and analyzed. Heart tube looping abnormalities include L-loop, ambiguous looping, or no looping. Left panels show all phenotypes after separate microinjection or co-microinjection of WT and mutant MMP21 mRNAs to zebrafish embryos. The right panels show normal and abnormal heart looping phenotypes. A, B Compared to the SB-MO group, MMP21 WT mRNA effectively reduced the number of malformed phenotypes. Mut1 and Mut3 could not effectively compensate for the effects of mmp21 knockdown. The effect of Mut2 was similar to that of the WT mRNA. C, D When co-microinjected with the WT and mutant mRNAs at a 1:1 ratio, no statistical difference in the malformation rate between the WT&Mut2 group and the WT mRNA group was noted. The malformation rate of the WT&Mu1 and WT&Mu3 groups was significantly reduced compared to that of the SB-MO group; however, it remained significantly higher than that of the WT mRNA group (chi-square test was used for statistical calculation, $ p < 0.0001 versus control MO group, #### p < 0.0001 versus SB-MO group, ## p < 0.01 versus SB-MO group, **** p < 0.0001 versus WT mRNA group, *** p < 0.001 versus WT mRNA group, ns: nonsignificant)

Full size image

WT&Mut1(c.731G > A) and WT&Mut3(c.1459A > G) heterozygous MMP21 mRNA could not fully rescue the abnormal left–right pattern caused by mmp21 knockdown in zebrafish.

Since all three MMP21 mutations detected in patients were heterozygous, we wondered whether heterozygosity affected WT MMP21 protein function. WT and mutant human MMP21 mRNA mix (WT/mutant = 1:1) was co-microinjected into mmp21 MO-knockdown zebrafish. The rescue experiment showed that WT&Mut2 (c.829C > T) heterozygous MMP21 mRNA mix could rescue the phenotypes caused by mmp21 knockdown similar to homozygous WT MMP21 mRNA (14.36% vs. 13.76%, p = 0.7962). The WT&Mut1 (c.731G > A) and WT&Mut3 (c.1459A > G) heterozygous MMP21 mRNA mix could partially rescue the phenotypes, compared to the homozygous Mut1 and Mut3 MMP21 mRNA; however, the malformation rate remained significantly higher than that of homozygous WT MMP21 mRNA (WT&Mut1: 25.06% vs. WT: 13.76%, p < 0.0001; WT&Mut3: 22.32% vs. WT: 13.76%, p = 0.0008) (Fig. 4). These results suggested that MMP21-G244E and MMP21-K487E may have a dominant-negative effect and increase susceptibility to abnormal left–right patterning, supporting their functional and clinical relevance.

Discussion

MMPs are a family of zinc-dependent endopeptidases critical for maintaining tissue allostasis under normal physiological conditions. ProMMPs are cleaved into their active forms and subsequently degrade various protein components of the extracellular matrix (ECM) [37]. Thus, MMPs are multifunctional proteins involved in tissue remodeling during various physiological processes (such as embryogenesis, morphogenesis, and angiogenesis) as well as pathological conditions (such as cancer, myocardial infarction, and osteoarthritis) [38, 39]. Twenty-eight members of the MMP family have been reported in vertebrates, whereas at least 23 have been detected in humans [38]. MMPs are further divided into gelatinases, matrilysin, collagenases, stromelysins, membrane-type MMPs, and other MMPs, depending on their substrate and structural domains [40].

Studies have shown that MMP1 and MMP2 are involved in modulating membrane motility and lumenogenesis during heart development in Drosophila flies [41]. MMP21, on the other hand, is a multifunctional secreted furin-containing MMP. Exploring its role in embryonic left–right axis establishment and cardiogenesis could potentially expand the functional profile of this protein family. Previous animal- and human-based studies have demonstrated that dysfunctional MMP21 protein predisposes patients to HTX [18, 19, 29,30,31,32]. Trio family pedigrees analysis using exome sequencing facilitates the identification of genetic alterations such as single nucleotide variants, copy number variations, and insertions/deletions (indels), which further validates the causal mutations in inherited diseases. In this study, three de novo heterozygous MMP21 variants (p.G244E, p.L277F, and p.K487E) were detected in three unrelated patients with HTX and complex CHDs by exome sequencing and Sanger sequencing. None of these variants affected MMP21 expression. Two of them (MMP21-G244E and MMP21-K487E) were loss-of-function mutations in both homozygous and heterozygous states based on zebrafish rescue experiments. Our results suggest that these two variants confer susceptibility to abnormal left–right patterning as well as abnormal cardiac development and may be involved in the pathogenesis of HTX. Functionally compromised MMP21 expression may underlie the occurrence of HTX and various congenital cardiac malformations in humans.

We also synthesized mutant MMP21 mRNA in vitro to rescue morphants. Zebrafish rescue experiments showed that heterozygous WT and p.G244E MMP21 mRNA mix as well as WT and p.k487E MMP21 mRNA mix could partially rescue the phenotypes caused by mmp21 knockdown via SB-MO. These results suggest that normal functioning MMP21 might play an important role in establishing the left–right axis and heart looping during early embryonic development in a quantity- and quality-dependent manner.

Previous studies have confirmed that MMPs are regulated at multiple levels, including mRNA transcription, conversion of the proenzyme to the active form, and inhibition of endogenous tissue inhibitors of metalloproteinases (TIMPs). Initially, MMPs are synthesized as pre-pro-MMPs and are then transformed into inactive pro-MMP by cleaving the signal peptide during translation. Our data indicated that the variants did not affect the transcription and translation of MMP21, suggesting that they may lead to the pathologic phenotype by affecting MMP21 activity. MMP21 consists of a pro-peptide, furin-like motif, catalytic metalloproteinase domain, hinge region, and hemopexin domain in the C-terminal [22]. The furin-like pro-protein convertase recognition sequence is the basis for intracellular activation of MMP21 through furin [42]. The identified variants are located in the catalytic metalloproteinase and hemopexin domains and thus may not affect the furin activation process. Tissue inhibitors of metalloproteinases (TIMPs) are endogenous protease inhibitors that regulate MMPs activation and function by binding to them in a 1:1 stoichiometric ratio [25] decreasing their ability to degrade ECM proteins. The catalytic metalloproteinase domain contains a zinc finger module (HEXXHXXGXXH), which forms the basis of enzymatic hydrolysis of MMPs. TIMP wedges into the catalytically active site cleft of MMPs and inhibits their activity and/or activation [25]. The MMP21-G244E and MMP21-L277F variants were mapped to highly the conserved catalytic domains (Fig. 1D). The MMP21-G244E variant in the catalytic metalloproteinase domain may affect the interaction between TIMP and MMP21 and ultimately affect MMP21 activity. Although MMP21-L277F was damaged by PROVEAN, PolyPhen2, and MutationTaster, this variant rescued the phenotypes caused by mmp21 knockdown in zebrafish (Fig. 4). This may be due to the leucine to phenylalanine substitution not affecting the acid-base status and having little effect on spatial configuration. Both glycine to glutamic acid substitution in p.G244 and lysine to glutamic acid substitution in p.K487 changed the charge of the amino acid residues which may have affected protein folding and function. The variant p.K487E is located in the hemopexin-like domain, which consists of four β-helices. The Hpx domain may confer substrate specificity and is involved in the recognition and catalytic degradation of ECM proteins [43]. Therefore, p.K487E may influence the degradation of MMP21 substrates. In addition, a pathogenic de novo dominant variant might drive the dominant-negative behavior by impairing the product of the wild-type allele. Our data suggest that the MMP21 variants p.G244E and p.K487E may act as dominant negatives, disturbing the cyclization process during zebrafish heart development, leading to the heart looping disorder phenotype. Also, MMP21-G244E and MMP21-K487E mutants are susceptible to abnormal left–right patterns and abnormal cardiac development, supporting the causal effect of MMP21 variants in the dextrocardia phenotype of HTX patients. Further studies are required to confirm whether MMP21-G244E and MMP21-K487E manifest a qualitatively similar but milder dominant-negative effect on MMP21 protein.

The genetic architecture of the HTX is complex. The current literature regarding the molecular basis of HTX implicates numerous genes in autosomal dominant, recessive, or X-linked modes of inheritance [44]. In addition, single-gene variants, aneuploidy, and pathogenic copy number variants have also been identified as causative factors of HTX [45]. In some instances, both autosomal dominant and recessive modes of inheritance have been reported for a single gene. For example, the NODAL antagonist DAND5 has been confirmed to pattern left/right body asymmetry by inhibiting the NODAL signaling pathway [46]. Specifically screening for the presence of DAND5 variants alone, a non-synonymous heterozygous variant of DAND5 (c.455G > A) was identified in two unrelated Portuguese patients with laterality defects and complex congenital heart defects, which first confirmed the autosomal dominant manner of DAND5 variant [47]. Interestingly, a homozygous disease-causing mutation in DAND5 (c.396_397dupCT, p.Y133Sfs*11) was screened out from a proband with HTX of Arab–Muslim descent, which as a novel recessive monogenic cause for HTX in humans [48]. These studies demonstrate that single-gene variants can serve as the molecular basis for the L-R pattern of HTX and congenital heart defects through both autosomal dominant and autosomal recessive modes of inheritance. Previous studies reported homozygous or compound heterozygous MMP21 mutants in patients with HTX [18, 19, 29,30,31,32], which indicates that biallelically damaging MMP21 variants are important in the left–right patterning of HTX. MMP21 variants currently identified in HTX patients with complex CHDs are summarized in Additional File 4. Of note, we detected only three heterozygous MMP21 mutants in this study. Zebrafish rescue experiments confirmed that simple heterozygous MMP21-G244E and MMP21-K487E are pathogenic to HTX. However, HTX is genetically heterogeneous, and previous studies have identified multiple genetic mutations involved in establishing left–right asymmetry, including NODAL signaling or primary ciliary dyskinesia-associated disease-causing genes. These destructive mutations could contribute to the pathogenesis of the cardiac and extracardiac phenotypes of patients with MMP21-mutated patients. Thus, we analyzed the exome sequencing data of MMP21-mutated patients to determine whether they had other potential HTX-causing genetic variants (Additional file 2: Table S2). In the patient with the MMP21-G244E mutation, two potential additional HTX-causing missense variants were found in ROCK2 (NM_004850, c.345G > C, p.Q115H, rs564194657) and NUP188 (NM_015354, c.5018C > T, p.P1673L, rs568477773). ROCK2B knockdown and ROCK signaling inhibition in animal models resulted in abnormal asymmetric gene expression and caused laterality defects in Xenopus, zebrafish, and chicken embryos [49,50,51]. In addition, previous studies have identified rare genic copy number variations and heterozygous variants of ROCK2 in patients with HTX. NUP188 Morpholino knockdown in Xenopus strongly disrupted morphological left–right development, and a rare NUP188 duplication was identified in an individual with HTX and CHD [51, 52]. In HTX patients, no pathogenic missense mutations have been identified. Although the ROCK2 and NUP188 variants are not proven to be pathogenic, online pathogenicity analysis showed that these two variants may be destructive to protein function. So even though we confirmed that MMP21-G244E mutants failed to rescue heart looping defects in zebrafish embryos, we cannot exclude that the identified ROCK2 and NUP188 variants may jointly lead to the occurrence of cardiac and extracardiac malformations in this case. We haven’t found any other known HTX disease-causing gene variants in the MMP21 p.L277F mutated case. Given that the missense variant of MMP21 p.L277F successfully rescued the abnormal cardiac tube phenotype, the exact cause of this case is unknown. Interestingly, the patient with the MMP21-K487E variant had no genetic variations in other causative genes related to HTX, indicating a vital role for the simple heterozygous MMP21-K487E variant in the development of left–right axis patterning and heart looping.

Currently, few studies have focused on the molecular mechanisms of extracellular remodeling-related genes in establishing laterality during embryonic development in vertebrates. As a highly orchestrated process, embryonic development is inseparable from timed expression and activation of protease/antiprotease systems [53, 54]. MMPs are crucial in regulating vasculogenesis and epithelial-to-mesenchymal transition during organogenesis [55]. MMP21 is a zinc-dependent ECM remodeling endopeptidase involved in ECM degradation and embryonic development regulation [26, 27]. MMP21 is produced in various ectodermal structures in a spatially and temporally regulated manner during human and mouse embryonic development [56]. MMP21 could be detected in mice embryos aged 10.5, 12.5, 13.5, and 16.5 days after fertilization, with an expression peak at 13.5 days [56]. As for zebrafish embryos, WISH results showed that MMP21 expression was restricted to Kupffer’s vesicles when left–right asymmetry was established [29]. However, the substrates and interactors of MMP21 that control the LR pattern have not yet been clarified, especially during embryonic development, and identifying them will help uncover the mechanisms underlying the relationship between MMP21 loss-of-function and HTX pathogenesis as well as deepen our understanding of left–right asymmetry during embryonic development.

Conclusion

In summary, our findings show that two de novo, heterozygous non-synonymous MMP21 variants p.G244E and p.K487E affect the establishment of left–right asymmetry in zebrafish as well as play an indispensable role in heart looping, supporting the causal effect of heterozygous MMP21 variants in the dextrocardia phenotype found in patients with HTX and CHDs. Our data provide new insight into the pathogenesis of HTX and further support the hypothesis that pathogenic heterozygous MMP21 mutations contribute to the genetic underpinnings of HTX in humans. Moreover, our findings expand the mutation spectrum of MMP21 in HTX and confer susceptibility to HTX with CHDs.

Availability of data and materials

The dataset analyzed in the current study is available from the corresponding author according to a reasonable request.

Abbreviations

HTX:

Heterotaxy syndrome

CHDs:

Congenital heart diseases

MMP:

Matrix metallopeptidase

WT:

Wild-type

SA:

Single atrium

SV:

Single ventricle

DORV:

Double-outlet right ventricle

L-TGA:

Levo-transposition of great arteries

CAVC:

Complete atrioventricular canal

TAPVC:

Total anomalous pulmonary venous connection

CSS:

Cardiosplenic syndrome

RAI:

Right atrial isomerism

PLSVC:

Persistent left superior vena cava

PS:

Pulmonary stenosis

VSD:

Ventricular septal defect

PAD:

Pulmonary artery dysplasia

AVSD:

Atrioventricular septal defect

ECM:

Extracellular matrix

TIMPs:

Tissue inhibitor of metalloproteinases

AAT:

Alpha-1-antitrypsin

References

  1. Blum M, Ott T. Animal left-right asymmetry. Curr Biol. 2018;28(7):R301-r304. https://doi.org/10.1016/j.cub.2018.02.073.

    CAS  Article  PubMed  Google Scholar 

  2. Soofi M, Alpert MA, Barbadora J, Mukerji B, Mukerji V. Human laterality disorders: pathogenesis, clinical manifestations, diagnosis, and management. Am J Med Sci. 2021;362(3):233–42. https://doi.org/10.1016/j.amjms.2021.05.020.

    Article  PubMed  Google Scholar 

  3. Sutherland MJ, Ware SM. Disorders of left-right asymmetry: heterotaxy and situs inversus. Am J Med Genet C Semin Med Genet. 2009;151(4):307–17. https://doi.org/10.1002/ajmg.c.30228.

    CAS  Article  Google Scholar 

  4. Soofi M, Alpert MA, Barbadora J, Mukerji B, Mukerji V. Human laterality disorders: pathogenesis, clinical manifestations, diagnosis, and management. Am J Med Sci. 2021. https://doi.org/10.1016/j.amjms.2021.05.020.

    Article  PubMed  Google Scholar 

  5. Kathiriya IS, Srivastava D. Left-right asymmetry and cardiac looping: implications for cardiac development and congenital heart disease. Am J Med Genet. 2000;97(4):271–9. https://doi.org/10.1002/1096-8628(200024)97:4%3c271::aid-ajmg1277%3e3.0.co;2-o.

    CAS  Article  PubMed  Google Scholar 

  6. Alongi AM, Kirklin JK, Deng L, Padilla L, Pavnica J, Romp RL, et al. Surgical management of heterotaxy syndrome: current challenges and opportunities. World J Pediatr Congenit Heart Surg. 2020;11(2):166–76. https://doi.org/10.1177/2150135119893650.

    Article  PubMed  Google Scholar 

  7. Banka P, Adar A, Schaetzle B, Sleeper LA, Emani S, Geva T. Changes in prognosis of heterotaxy syndrome over time. Pediatrics. 2020. https://doi.org/10.1542/peds.2019-3345.

    Article  PubMed  Google Scholar 

  8. Swisher M, Jonas R, Tian X, Lee ES, Lo CW, Leatherbury L. Increased postoperative and respiratory complications in patients with congenital heart disease associated with heterotaxy. J Thorac Cardiovasc Surg. 2011;141(3):637–44. https://doi.org/10.1016/j.jtcvs.2010.07.082.

    Article  PubMed  Google Scholar 

  9. Kim JS, Seo JW, Lee YM, Chi JG. Cardiac laterality and ventricular looping in retinoic acid-treated rat embryos. J Korean Med Sci. 1999;14(2):138–46. https://doi.org/10.3346/jkms.1999.14.2.138.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. Splitt M, Wright C, Sen D, Goodship J. Left-isomerism sequence and maternal type-1 diabetes. Lancet. 1999;354(9175):305–6. https://doi.org/10.1016/s0140-6736(99)01942-x.

    CAS  Article  PubMed  Google Scholar 

  11. Kuehl KS, Loffredo C. Risk factors for heart disease associated with abnormal sidedness. Teratology. 2002;66(5):242–8. https://doi.org/10.1002/tera.10099.

    CAS  Article  PubMed  Google Scholar 

  12. Mohapatra B, Casey B, Li H, Ho-Dawson T, Smith L, Fernbach SD, et al. Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Hum Mol Genet. 2009;18(5):861–71. https://doi.org/10.1093/hmg/ddn411.

    CAS  Article  PubMed  Google Scholar 

  13. Kosaki K, Bassi MT, Kosaki R, Lewin M, Belmont J, Schauer G, et al. Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. Am J Hum Genet. 1999;64(3):712–21. https://doi.org/10.1086/302289.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. Kosaki R, Gebbia M, Kosaki K, Lewin M, Bowers P, Towbin JA, et al. Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet. 1999;82(1):70–6. https://doi.org/10.1002/(sici)1096-8628(19990101)82:1%3c70::aid-ajmg14%3e3.0.co;2-y.

    CAS  Article  PubMed  Google Scholar 

  15. Zhu L, Harutyunyan KG, Peng JL, Wang J, Schwartz RJ, Belmont JW. Identification of a novel role of ZIC3 in regulating cardiac development. Hum Mol Genet. 2007;16(14):1649–60. https://doi.org/10.1093/hmg/ddm106.

    CAS  Article  PubMed  Google Scholar 

  16. Kaasinen E, Aittomäki K, Eronen M, Vahteristo P, Karhu A, Mecklin JP, et al. Recessively inherited right atrial isomerism caused by mutations in growth/differentiation factor 1 (GDF1). Hum Mol Genet. 2010;19(14):2747–53. https://doi.org/10.1093/hmg/ddq164.

    CAS  Article  PubMed  Google Scholar 

  17. Bamford RN, Roessler E, Burdine RD, Saplakoğlu U, dela Cruz J, Splitt M, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet. 2000;26(3):365–9. https://doi.org/10.1038/81695.

    CAS  Article  PubMed  Google Scholar 

  18. Li AH, Hanchard NA, Azamian M, D’Alessandro LCA, Coban-Akdemir Z, Lopez KN, et al. Genetic architecture of laterality defects revealed by whole exome sequencing. Eur J Hum Genet. 2019;27(4):563–73. https://doi.org/10.1038/s41431-018-0307-z.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. Liu H, Giguet-Valard AG, Simonet T, Szenker-Ravi E, Lambert L, Vincent-Delorme C, et al. Next-generation sequencing in a series of 80 fetuses with complex cardiac malformations and/or heterotaxy. Hum Mutat. 2020;41(12):2167–78. https://doi.org/10.1002/humu.24132.

    CAS  Article  PubMed  Google Scholar 

  20. Sempou E, Khokha MK. Genes and mechanisms of heterotaxy: patients drive the search. Curr Opin Genet Dev. 2019;56:34–40. https://doi.org/10.1016/j.gde.2019.05.003.

    CAS  Article  PubMed  Google Scholar 

  21. Bolkier Y, Barel O, Marek-Yagel D, Atias-Varon D, Kagan M, Vardi A, et al. Whole-exome sequencing reveals a monogenic cause in 56% of individuals with laterality disorders and associated congenital heart defects. J Med Genet. 2021. https://doi.org/10.1136/jmedgenet-2021-107775.

    Article  PubMed  Google Scholar 

  22. Liang S, Shi X, Yu C, Shao X, Zhou H, Li X, et al. Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165906. https://doi.org/10.1016/j.bbadis.2020.165906.

    CAS  Article  PubMed  Google Scholar 

  23. Huang Y, Li W, Chu D, Zheng J, Ji G, Li M, et al. Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer. J Gastrointest Surg. 2011;15(7):1188–94. https://doi.org/10.1007/s11605-011-1519-5.

    Article  PubMed  Google Scholar 

  24. Zhao Z, Yan L, Li S, Sun H, Zhou Y, Li X. Increased MMP-21 expression in esophageal squamous cell carcinoma is associated with progression and prognosis. Med Oncol. 2014;31(8):91. https://doi.org/10.1007/s12032-014-0091-8.

    CAS  Article  PubMed  Google Scholar 

  25. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562–73. https://doi.org/10.1016/j.cardiores.2005.12.002.

    CAS  Article  PubMed  Google Scholar 

  26. Marchenko GN, Marchenko ND, Strongin AY. The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein. Biochem J. 2003;372(Pt 2):503–15. https://doi.org/10.1042/bj20030174.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. Ahokas K, Lohi J, Lohi H, Elomaa O, Karjalainen-Lindsberg ML, Kere J, et al. Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer. Gene. 2002;301(1–2):31–41. https://doi.org/10.1016/s0378-1119(02)01088-0.

    CAS  Article  PubMed  Google Scholar 

  28. Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ, Lemke K, et al. Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature. 2015;521(7553):520–4. https://doi.org/10.1038/nature14269.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. Guimier A, Gabriel GC, Bajolle F, Tsang M, Liu H, Noll A, et al. MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates. Nat Genet. 2015;47(11):1260–3. https://doi.org/10.1038/ng.3376.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. Perles Z, Moon S, Ta-Shma A, Yaacov B, Francescatto L, Edvardson S, et al. A human laterality disorder caused by a homozygous deleterious mutation in MMP21. J Med Genet. 2015;52(12):840–7. https://doi.org/10.1136/jmedgenet-2015-103336.

    CAS  Article  PubMed  Google Scholar 

  31. Yuan ZZ, Fan LL, Jiang ZC, Yang YF, Tan ZP. A novel nonsense MMP21 variant causes dextrocardia and congenital heart disease in a Han Chinese patient. Front Cardiovasc Med. 2020;7:582350. https://doi.org/10.3389/fcvm.2020.582350.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  32. Akawi N, McRae J, Ansari M, Balasubramanian M, Blyth M, Brady AF, et al. Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families. Nat Genet. 2015;47(11):1363–9. https://doi.org/10.1038/ng.3410.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8. https://doi.org/10.1038/nprot.2008.73.

    CAS  Article  PubMed  Google Scholar 

  34. Li Z, Li B, Wang J, Lu Y, Chen AFY, Sun K, et al. GAA deficiency promotes angiogenesis through upregulation of Rac1 induced by autophagy disorder. Biochim Biophys Acta Mol Cell Res. 2021;1868(5):118969. https://doi.org/10.1016/j.bbamcr.2021.118969.

    CAS  Article  PubMed  Google Scholar 

  35. Rottbauer W, Wessels G, Dahme T, Just S, Trano N, Hassel D, et al. Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart. Circ Res. 2006;99(3):323–31. https://doi.org/10.1161/01.RES.0000234807.16034.fe.

    CAS  Article  PubMed  Google Scholar 

  36. Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res. 2011;91(2):279–88. https://doi.org/10.1093/cvr/cvr098.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75(2):346–59. https://doi.org/10.1016/j.bcp.2007.07.004.

    CAS  Article  PubMed  Google Scholar 

  38. Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73. https://doi.org/10.1016/bs.pmbts.2017.02.005.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. Serra R. Matrix metalloproteinases in health and disease. Biomolecules. 2020. https://doi.org/10.3390/biom10081138.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wang X, Khalil RA. Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv Pharmacol. 2018;81:241–330. https://doi.org/10.1016/bs.apha.2017.08.002.

    CAS  Article  PubMed  Google Scholar 

  41. Raza QS, Vanderploeg JL, Jacobs JR. Matrix Metalloproteinases are required for membrane motility and lumenogenesis during drosophila heart development. PLoS ONE. 2017;12(2):e0171905. https://doi.org/10.1371/journal.pone.0171905.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 1995;375(6528):244–7. https://doi.org/10.1038/375244a0.

    CAS  Article  PubMed  Google Scholar 

  43. Suenaga N, Mori H, Itoh Y, Seiki M. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene. 2005;24(5):859–68. https://doi.org/10.1038/sj.onc.1208258.

    CAS  Article  PubMed  Google Scholar 

  44. Wells JR, Padua MB, Ware SM. The genetic landscape of cardiovascular left-right patterning defects. Curr Opin Genet Dev. 2022;75:101937. https://doi.org/10.1016/j.gde.2022.101937.

    CAS  Article  PubMed  Google Scholar 

  45. Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American heart association. Circulation. 2018;138(21):e653–711. https://doi.org/10.1161/cir.0000000000000606.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Kawasumi A, Nakamura T, Iwai N, Yashiro K, Saijoh Y, Belo JA, et al. Left-right asymmetry in the level of active Nodal protein produced in the node is translated into left-right asymmetry in the lateral plate of mouse embryos. Dev Biol. 2011;353(2):321–30. https://doi.org/10.1016/j.ydbio.2011.03.009.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  47. Cristo F, Inácio JM, de Almeida S, Mendes P, Martins DS, Maio J, et al. Functional study of DAND5 variant in patients with congenital heart disease and laterality defects. BMC Med Genet. 2017;18(1):77. https://doi.org/10.1186/s12881-017-0444-1.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  48. Bolkier Y, Barel O, Marek-Yagel D, Atias-Varon D, Kagan M, Vardi A, et al. Whole-exome sequencing reveals a monogenic cause in 56% of individuals with laterality disorders and associated congenital heart defects. J Med Genet. 2022;59(7):691–6. https://doi.org/10.1136/jmedgenet-2021-107775.

    Article  PubMed  Google Scholar 

  49. Wei L, Roberts W, Wang L, Yamada M, Zhang S, Zhao Z, et al. Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development. 2001;128(15):2953–62.

    CAS  Article  Google Scholar 

  50. Wang G, Cadwallader AB, Jang DS, Tsang M, Yost HJ, Amack JD. The rho kinase Rock2b establishes anteroposterior asymmetry of the ciliated Kupffer’s vesicle in zebrafish. Development. 2011;138(1):45–54. https://doi.org/10.1242/dev.052985.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  51. Fakhro KA, Choi M, Ware SM, Belmont JW, Towbin JA, Lifton RP, et al. Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci USA. 2011;108(7):2915–20. https://doi.org/10.1073/pnas.1019645108.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Del Viso F, Huang F, Myers J, Chalfant M, Zhang Y, Reza N, et al. Congenital heart disease genetics uncovers context-dependent organization and function of nucleoporins at cilia. Dev Cell. 2016;38(5):478–92. https://doi.org/10.1016/j.devcel.2016.08.002.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  53. Ryu J, Vicencio AG, Yeager ME, Kashgarian M, Haddad GG, Eickelberg O. Differential expression of matrix metalloproteinases and their inhibitors in human and mouse lung development. Thromb Haemost. 2005;94(1):175–83. https://doi.org/10.1160/th04-10-0656.

    CAS  Article  PubMed  Google Scholar 

  54. Muñoz-Sáez E, Moracho N, Learte AIR, Arroyo AG, Sánchez-Camacho C. Dynamic expression of membrane type 1-matrix metalloproteinase (Mt1-mmp/Mmp14) in the mouse embryo. Cells. 2021. https://doi.org/10.3390/cells10092448.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Moracho N, Learte AIR, Muñoz-Sáez E, Marchena MA, Cid MA, Arroyo AG, et al. Emerging roles of MT-MMPs in embryonic development. Dev Dyn. 2021. https://doi.org/10.1002/dvdy.398.

    Article  PubMed  Google Scholar 

  56. Ahokas K, Lohi J, Illman SA, Llano E, Elomaa O, Impola U, et al. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes. Lab Invest. 2003;83(12):1887–99. https://doi.org/10.1097/01.lab.0000106721.86126.39.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all participants for their efforts and contribution to this work. We thank Yu-jiao Ye and Jing Wang for their assistance in the WISH experiment. We also thank the colleague in the Department of Pediatric Cardiology of Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine for their support in this work.

Funding

This work received financial support from the National Natural Science Foundation of China (No.81771623, No.82071936), the Shanghai Pujiang Program (20PJ1410100), and the Collaborative Innovation Program of the Shanghai Municipal Health Commission (2020CXJQ01).

Author information

Author notes

  1. Xi-ji Qin and Meng-meng Xu contributed equally to this article

Authors and Affiliations

  1. Department of Pediatric Cardiology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Room 505, Scientific Building, Shanghai, 200092, China

    Xi-ji Qin, Meng-meng Xu, Jia-jun Ye, Yi-wei Niu, Yu-rong Wu, Sun Chen, Kun Sun & Yue-juan Xu

  2. Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China

    Meng-meng Xu

  3. Scientific Research Center, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China

    Rang Xu

  4. Department of Pediatric Cardiology, Shanghai Children’s Medical Center, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China

    Fen Li

  5. Medical Laboratory, Shanghai Children’s Medical Center, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China

    Qi-hua Fu

Authors
  1. Xi-ji Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meng-meng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jia-jun Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi-wei Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-rong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qi-hua Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yue-juan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XQ and MX performed experiments, analyzed the data, and drafted the manuscript. JY and YN helped to analyze the data. YW, RX, FL, and QF helped to collect the cohort and review the clinical information. YX, SC, and KS designed the study. YX analyzed the data and revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Sun Chen, Kun Sun or Yue-juan Xu.

Ethics declarations

Ethics approval and consent to participate

The human experimentations were approved by the Medical Ethics Committee of Xinhua Hospital (No. XHEC-C-2012–018) and Shanghai Children’s Medical Center (No. SCMC-201015). Human peripheral blood samples were extracted voluntarily when donors signed the informed consent (or their parents/guardian if the donors were too young to consent). Zebrafish experiments were conducted under the approval of the Animal Ethics Committee of Xinhua Hospital, affiliated to Shanghai Jiao Tong University School of Medicine.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Primers used for Sanger sequencing validation of MMP21 variants, mutagenesis of mutant MMP21 vectors, RT-qPCR, and construction of in situ hybridization probes.

Additional file 2: Table S2.

Clinical information and HTX-related genetic variants in HTX patients with MMP21 variants.

Additional file 3: Table S3.

The variants of potential causative genes related to HTX identified in the clinical cohort.

Additional file 4: Table S4.

The MMP21 variants currently identified in HTX patients with complex CHDs.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Qin, Xj., Xu, Mm., Ye, Jj. et al. De novo disruptive heterozygous MMP21 variants are potential predisposing genetic risk factors in Chinese Han heterotaxy children. Hum Genomics 16, 41 (2022). https://doi.org/10.1186/s40246-022-00409-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40246-022-00409-9

Keywords

  • Congenital heart disease
  • Heterotaxy syndrome
  • MMP21
  • Exome sequencing
  • Zebrafish

Human Genomics

ISSN: 1479-7364